Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals

Friday, January 18, 2019

AMAG Pharmaceuticals Inc announced today that it has completed the previously announced acquisition of Perosphere Pharmaceuticals Inc a private biopharmaceutical company Through this acquisition AMAG adds ciraparantag to its development portfolio Ciraparantag is in development as a single dose ready..

Ablexis Announces Expansion of Non-Exclusive Perpetual License Agreement with Eli Lilly and Company

Friday, January 18, 2019

Ablexis LLC a biopharmaceutical company focused on licensing its AlivaMab Mouse platform technology for antibody drug discovery today announced the expansion of its existing nonexclusive perpetual license agreement with Eli Lilly and Company The expanded rights will more broadly enable EIi Lilly to ..

Phoenix Molecular Designs Announces Collaboration To Develop Diagnostic for Triple-Negative Breast Cancer

Thursday, January 17, 2019

Phoenix Molecular Designs a privatelyheld biotechnology company designing precise cancer therapeutics by targeting essential kinases announced that it has entered into a collaboration with Roche to develop a diagnostic CDx in triplenegative breast cancer TNBC The Roche CDx identifies RSK2 activation..

Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field

Thursday, January 17, 2019

Luye Pharma has announced it has entered an agreement with AstraZeneca China the terms of which grant AstraZeneca China exclusive rights to promote Luye Pharma39s Xuezhikang Capsules in mainland China This is the first time that a multinational pharmaceutical company has gained exclusive authorizati..

Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases

Wednesday, January 16, 2019

Ascletis Pharma Inc and Suzhou Alphamab Co Ltd Alphamab jointly announce today that Ascletis39 subsidiary and Alphamab have entered into a strategic collaboration and exclusive licensing agreement for antiPDL1 KN035 to treat hepatitis B and other viral diseases in Greater China Ascletis code ASC22 K..

Bioharmony Therapeutics and Boehringer Ingelheim Collaborate to Advance Bacteriophage Lysin Therapeutics

Wednesday, January 16, 2019

Bioharmony Therapeutics Inc a biopharmaceutical company focusing on the development of novel therapeutics for hard to treat bacterial infections announced today that it has entered into a Collaborative Research and Licensing Agreement with Boehringer Ingelheim to develop bacteriophage lysins for the..

Amarantus Announces Commercialization Partnership With IDEA Pharma for Subsidiaries

Friday, January 11, 2019

Amarantus Bioscience Holdings Inc a USbased JLABSalumnus biotechnology holding company developing firstinclass orphan neurologic regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries and IDEA Pharma Ltd a UKbased pathtomarket strategy and applied innovation consulti..

SIRION Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System

Thursday, January 10, 2019

SIRION Biotech GmbH a world leader in viral vectorbased gene delivery technologies for gene cell therapy announced today that it signed a license and collaboration agreement with Denali Therapeutics a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative..

AbSci Establishes New Collaboration with Sanofi

Thursday, January 10, 2019

AbSci a global leader in biotherapeutic discovery and manufacturing technologies today announced a collaboration with Sanofi Under the terms of the agreement AbSci will apply its breakthrough Ecoli manufacturing platform SoluProTM and its novel optimization assay system to two of Sanofi39s biotherap..

Generex Biotechnology Completes Acquisition of Olaregen Therapeutix Inc.

Wednesday, January 09, 2019

Generex Biotechnology Corporation is pleased to announce that the company has completed the acquisition of 51 of Olaregen Therapeutix Inc a New York based regenerative medicine company that is preparing to launch its proprietary patented wound conforming gel matrix Excellagen an FDA 510K Cleared wou..